alexa The Humoral and Cellular Immune Response Characteristic of Propolis Flavonoid Used as Adjuvant to Inactivated PPV Vaccine in Sows | Open Access Journals
ISSN: 2161-1009
Biochemistry & Analytical Biochemistry
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

The Humoral and Cellular Immune Response Characteristic of Propolis Flavonoid Used as Adjuvant to Inactivated PPV Vaccine in Sows

Xia Ma1,2, Zhenhuan Guo2, Yonglu Liu1, Yanzhou Zhou1, Xiaolin Wang1, Zhiqiang Shen2* and Jinliang Wang2

1Medicinal Engineering Department of Henan University of Animal Husbandry and Economy, Zhengzhou, P.R. China

2Binzhou Animal Science and Veterinary Medicine Academy of Shandong Province, P.R. China

*Corresponding Author:
Zhiqiang Shen
Binzhou Animal Science and
Veterinary Medicine Academy of Shandong Province
No.169 Huanghe 2nd Road, Binzhou
Shnadong 256600, P.R. China
Tel: +86-543-3405108
Fax: +86-543-3252652
E-mail: [email protected]

Received Date: December 12, 2015; Accepted Date: January 25, 2016; Published Date: February 28, 2016

Citation: Ma X, Guo Z, Liu Y, Zhou Y, Wang X, et al. (2016) The Humoral and Cellular Immune Response Characteristic of Propolis Flavonoid Used as Adjuvant to Inactivated PPV Vaccine in Sows. Biochem Anal Biochem 5:242. doi:10.4172/2161-1009.1000242

Copyright: © 2016 Ma X, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biochemistry & Analytical Biochemistry

Abstract

The present study was conducted to assess the effects of propolis flavonoid used as adjuvant on the immune response of Landrace-Yorkshire hybrid sows immunized with an inactivated vaccine of porcine parvovirus (PPV). Thirty Landrace-Yorkshire hybrid sows were randomly assigned to one of 3 groups, and the sows in two adjuvant groups were intramuscular injected PPV vaccine with 2.0 mL propolis flavonoid adjuvant (PA) or oilemulsion adjuvant (OA), respectively. After that, serum hemagglutination inhibition antibody titers, specific IgM, IgA and IgG subclasses were measured to estimate the humoral immunity for the adjuvant effects of propolis flavonoid, as well as peripheral lymphopoiesis activity, and lymphocyte factor concentrations of Th1 and Th2 for cellular immune responses. Results indicated in a significant enhancing effect of PA on concentrations of IgM, IgG2, IgG3, IL-2 and IFN-γ comparing to OA. Especially in improving the effect of Th1 cellular immune response, the PA was superior to OA. These findings suggested that PA can significantly enhance the immune responses against PPV vaccine and could be exploited to a new PPV vaccine in sows.

Keywords

Propolis flavonoid; Porcine parvovirus; Immunological adjuvant; Humoral immune response; Cellular immune response.

Introduction

Propolis, applied as a traditional cure in folk medicine empirically for centuries, is a mix ingredients composeed by honeybees with various plant resinous and mandibular gland secretion [1]. It is well known for latent health benefit and is reported to own valuable biological activities, including antivirus, immune enhancement, antibiosis, antioxidation, hepatoprotection, anticancer, anti-fatigue, and so on [2-4]. It is an splendid immune system booster and natural antibiotic with no sideeffect. In recent years, propolis has become an issue of increasing interest in the investigators for its versatile biological activities and broadly exchanged by the pharmaceutical industries as the health-food and an alternative medicine in various parts of the world.

Propolis flavonoid (PF) is a kind of ingredients extracted from propolis and has been used as a harmless natural adjuvant in chickens vaccinated with activated vaccine, and the results showed that PF could remarkably improve the immune activity in the cellular and humoral immune response [2,4]. But the adjuvant effects and feature PF on inactivated vaccine to sows had not be considered detailedly in humoral and cellular immunity response.

Recently, the animal viral infectious diseases, such as severe untypical classical swine fever, acute respiratory syndrome, cow transmissible spongiform encephalopathy, swine hyperpyrexia disease and so on are worldwide concerned as they made a stage of comeback with emerge continuously and spread quickly, and constantly cause a enormous loss in domestic animal and poultry industry [5]. PPV could cause reproductive failure in pregnant sows, which is characterized by stillbirths, fetal and embryonic death, mummification and delayed return to oestrus [6]. Although the acute infection of postnatal and non-pregnant pigs is often sub-clinical, PPV has been linked to skin lesion occurrence in piglets [7], non-suppurative myocarditis in lactating piglets and interstitial nephritis in slaughter aged pigs [8].

Several research results have pointed out that vaccination is the effective method for controlling viral disease [9,10]. The ideal and successful vaccination depends on the association with antigen and potent adjuvant which can increase the immune effect of vaccine. A desired adjuvant could not only start specific effectors of the immune system to strengthen the cellular and/or humoral immune responses against that antigen, but also activate auxiliary or cytotoxic T cells [8,11,12]. On the other hand, better adjuvant should have no or lower toxicity and side effects [13]. But there are many deficiencies in commonly used adjuvant, for instance, oilemulsion adjuvant (OA) can cause induration or necrosis in the local, acute inflammation and disseminated granulomas in lungs, lymph nodes and skeletal muscles in rats or rabbits [14]. Therefore, it is urgent to explore a new adjuvant with high humoral and cellular immunity efficacy and security.

Our previous studies demonstrated that PF possessed a better immunological enhancement on cellular and humoral immunity in model animal of guinea pig inactivated PPV vaccine [15]. In this study, the authors determined the effects of PF on serum antibody tiers, immunoglobulin (Ig)M, IgA and IgG subclass for humoral immunity, and peripheral lymphopoiesis and lymphocyte excretion of Th1 cytokine (interleukin (IL)-2 and interferon (IFN)-γ) and Th2 cytokine (IL-4, IL-6, IL-10 and IL-12) for cellular immunity of pigs vaccinated with inactivated PPV vaccine compared with OA. Thus, the aim of this study was to observe the adjuvant effect and characteristic of PF on immune response of immunized sows and offer theoretical evidence for developing PF into PPV vaccine adjuvant.

Materials and Methods

Preparation of adjuvant and vaccine

Propolis was purchased from Shandong province Qingkun Beeswax honeycomb processing factory. PF was prepared in our laboratory in a final purity of 925 mg·g-1. The PF adjuvant (PA) was prepared as previoulsy described [16]. The PF was dissolved with phosphate buffer solution (PBS, pH 6.2) in a final concentration of 40 mg·mL-1. PPV, the virus contained 2048 haemagglutination units (HAU)·mL-1, was obtained from China Institute of Veterinary Drug Control. The adjuvant vaccines containing PA or OA were prepared by Lvdu Veterinary Biologicals Co. Ltd., Binzhou, China. Their virus antigen contents were the same.

Main reagents

RPMI-1640 (Gibco) supplemented with streptomycin 100 IU·mL-1, benzylpenicillin 100 IU·mL-1 and 10% fetal bovine serum (FBS), was used for re-suspending and washing the cells, culturing and dilutingthe mitogen the cells. The mitogen of concanavalin A (ConA, Sigma) was dissolved with 0.1 mg·mL-1 RPMI-1640. Sodium heparin was dissolved with 5 mg·mL-1 of PBS. The 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT, Amresco Co.) was dissolved into 5 mg·mL-1 with calcium and magnesium free (CMF) PBS (pH 7.4). These reagents were all filtered through a 0.22 μm syringe filter. Dimethyl sulfoxide (DMSO) was purchased from Shanghai Lingfeng Chemical Reagent Ltd. Lymphocytes separation medium was purchased from Tianjing Haoyang Biological Manufacture co. Ltd. The enzyme-linked immunosorbent assay (ELISA) kits for IgM, IgA, IgG1, IgG2, IgG3, IgG4, IL-2, IFN-γ, IL-4, IL-6, IL-10 and IL-12 were purchased from R&D Systems Inc., Minneapolis, USA.

Animals, housing and treatment

Thirty Landrace-Yorkshire hybrid sows (aged from 198 to 204, and average weight is 64.5 kg) were randomly assigned to one of 3 groups, receiving intramuscular injection of PPV vaccine with 2.0 mL PA, OA or physiological saline (blank control group, BC group), respectively. The animals were kept in ten pigpens divide equally under standard conditions in the Experimental Animal Center of Shandong province Animal Science and Veterinary Medicine Academy of Binzhou, ( NO. SYXK (lu) 20110066 ). They were maintained in an air-conditioned room with light from 06:00 h to 18:00 h. The room temperature (24 ± 3oC) and humidity were controlled automatically. They were fed water and food ad libitum. All the experiment animals of procedures and their care conformed to the internationally accepted principles as found by the government of China for the Guidelines for Keeping Experimental Animals issued. The antibody against PPV was negative before the experiment.

On days 7, 14, 21, 28, 35 and 42 after vaccination, the blood of 6 sows randomly from each group were sampled for measuring PPV serum hemagglutination inhibition (HI) antibody titer by micro-method, IgM, IgA and IgG subclasses with method of ELISA kit dynamically and continuously. On days 7, 14, 21, 28, 35 and 42 after vaccination, the peripheral blood of 4 pigs randomly from each group were sampled for examination of lymphocyte proliferation by MTT assay [17] and analyzing lymphocyte cytokine of IL-2, IFN-γ, IL-4, IL-6, IL-10 and IL-12 by ELISA kit [16].

Statistical analysis

Data are expressed as the mean ± S.D. LSD’s and Duncan multiple range test was used to determine the differences among groups. P-values of less than 0.05 were considered statistically significant.

Results

The serum variation antibody titer

The serum dynamic variation HI antibody titers of each group are demonstrated in Table 1. The HI antibody titers in PA and OA vaccination groups improved significantly (p<0.05) from days 7 to 42 compared with the BC group. On days 7 and 14 after vaccination, the HI antibody titers in PA group were higher than OA group (p>0.05). On days 21, 28, 35 and 42, the HI antibody titers in group PA were lower significantly than those of group OA (p<0.05).

Group D7 D14 D21 D28 D35 D42
PA 4.5 ± 0.4a 7.4 ± 0.5a 7.5 ± 0.4b 7.8 ± 0.7b 7.3 ± 0.5b 6.5 ± 0.5b
OA 4.3 ± 0.5a 7.3 ± 0.5a 8.5 ± 0.6a 8.8 ± 0.5a 8.3 ± 0.7a 7.5 ± 0.7a
BC 0 ± 0b 0 ± 0b 0 ± 0c 0 ± 0c 0 ± 0c 0 ± 0c

Table 1: The dynamic variation of HI antibody titer after vaccination (log2).

The serum variation of IgM and IgA content

The serum variation of IgM content of every group is illustrated in Figure 1A. On days 7 and 21 after vaccination, IgM content of PA group was higher than that of OA group (p<0.05), while on days 14, 28, 35 and 42 after vaccination, IgM content of PA group only was numerically higher (p>0.05) than that of OA group, and higher significantly (p<0.05) than that of BC group.

biochemistry-analytical-biochemistry-vaccination

Figure 1: The dynamic changes of IgM and IgA content after vaccination (μg·mL-1). a-c Bars in the same day without the same superscripts differ significantly (p<0.05).

The serum variation of IgA content of every group is shown in Figure 1B. From 7 to 42 after immunization, the IgA content in group PA, OA and BC had no significant ((p>0.05).

The serum variation of IgG subclasses content

The serum variation of IgG1 content of every group is illustrated in Figure 2A. The IgG1 content in PA and OA adjuvant groups was higher significantly (p<0.05) than that of BC group from 14 to 35 after vaccination. On day 7 after vaccination, IgG1 content of PA group was higher (p>0.05) than that of OA group. But on 21 and 28, the IgG1 content in OA adjuvant group was higher significantly (p<0.05) than that of PA group.

biochemistry-analytical-biochemistry-superscripts

Figure 2: The changes of IgG1, IgG2, IgG3 and IgG4 content after vaccination (μg·mL-1). a-c Bars in the same day without the same superscripts differ significantly (p<0.05).

The serum variation of IgG2 content of every group is shown in Figure 2B. The IgG2 content in PA and OA adjuvant groups was higher significantly (p<0.05) than that of BC group from 7 to 28 after vaccination. On day 14 and 21 after vaccination, IgG2 content of PA group was higher significantly (p<0.05) than that of OA group.

The serum variation of IgG3 content of every group is illustrated in Figure 2C. The IgG3 content in PA and OA adjuvant groups was higher significantly (p<0.05) than that of BC group from 7 to 35 after vaccination. On day 7 and 14 after vaccination, IgG3 content of PA group was higher significantly (p<0.05) than that of OA group.

The serum variation of IgG4 content of every group is shown in Figure 2D. The IgG4 content in OA adjuvant group was higher significantly (p<0.05) than that of BC group on day 7 and 21 after vaccination. From 7 to 42 after vaccination, the IgG4 content of PA group was lower (p>0.05) than that of OA group.

Peripheral lymphocyte proliferation activity

The lymphocyte proliferation activities are shown in Table 2. The A570 values of PA group were significantly bigger than those of the OA and BC groups from days 7 to 28 after vaccination significantly (p<0.05). On day 7 and 21 after vaccination, the A570 values in OA group were bigger significantly (p<0.05) than that of BC group.

Group D7 D14 D21 D28 D35 D42
PA 0.36 ± 0.02a 0.33 ± 0.01a 0.37 ± 0.02a 0.30 ± 0.01a 0.29 ± 0.01a 0.28 ± 0.01a
OA 0.32 ± 0.01b 0.29 ± 0.02b 0.34 ± 0.02b 0.27 ± 0.02b 0.28 ± 0.02a 0.29 ± 0.02a
BC 0.29 ± 0.02c 0.28 ± 0.01b 0.30 ± 0.01c 0.26 ± 0.02b 0.27 ± 0.02a 0.27 ± 0.01a

Table 2: The changes in lymphocyte proliferation of blood (A570 value).

Th1 cytokine level

Th1 cytokine of IL-2 content is listed as Figure 3A. The IL-2 content in PA group was significantly higher (p<0.05) than those of OA and BC groups from 7 to 42 after vaccination. And on day 7 and 21 after vaccination, IL-2 content of OA group was higher significantly (p<0.05) than that of BC group.

biochemistry-analytical-biochemistry-significantly

Figure 3: The dynamic changes of IL-2 and IFN-γ content after vaccination (μg·mL-1). a-c Bars in the same day without the same superscripts differ significantly (p<0.05).

Th1 cytokine of IFN-γ content is listed as Figure 3B. PA triggered stronger IFN-γ content significantly (p<0.05) than the OA group from 7 to 42 after vaccination.

Th2 cytokine level

Th2 cytokine of IL-4 content is shown in Figure 4A. The IL-4 content in PA group was significantly lower (p<0.05) than that of OA group from 7 to 42 after vaccination. And on day 7 and 21 after vaccination, IL-4 content in PA group was significantly lower (p<0.05) than that of BC group.

biochemistry-analytical-biochemistry-vaccination

Figure 4: The changes of IL-4, IL-6, IL-10 and IL-12 content after vaccination (μg·mL-1). a-c Bars in the same day without the same superscripts differ significantly (p<0.05).

Th2 cytokine of IL-6 content is shown in Figure 4B. The IL-6 content in PA group was lower (p>0.05) than that of OA group from 7 to 42 after vaccination.

Th2 cytokine of IL-10 content is illustrated in Figure 4C. The IL-10 content in PA group was significantly lower (p<0.05) than those of OA and BC groups from 7 to 28 after vaccination.

Th2 cytokine of IL-12 content is illustrated in Figure 4D. The IL-12 content in PA group was lower (p>0.05) than that of OA group from 7 to 42 after vaccination.

Discussion

The combinations of adjuvant may combine multiple adjuvant components to achieve the desired mix of immune responses. During early period (7 d) of vaccination, our studies suggested that the serum HI antibody titer against PPV and IgM content of group PA were higher than that of group OA, which suggested that the PA was superior to the OA in the early vaccination. This could get the immuned animals more effectively on resisting wild virus infection. In mice model, Orsatti also verified that propolis could start the initial steps of the immune response [18].

There are different subclasses of IgG in serum such as IgG1, IgG2, IgG3 and IgG4 that afford the bulk of immunity to most infectious disease. Raised antibody titers are very important for microbial killing by way of antibody-mediated mechanisms. Our data showed that IgG2 and IgG3 contents were significantly higher in the sows immunized with PA than that of immunized with OA, indicating that PF acts synergistically to promote the IgG subclasses production. Sforcin also concluded that PF stimulates antibody production [19]. And studies in the animal models have shown that antibodies play a significant role in the immune system to defense against PPV [19-22].

PF enhances immune responses in various ways such as formation of the immunostimulating complex, activation of helper and cytotoxic T cells. In addition to activating the humoral immune response, PF also increased cellular immune responses [23,24]. In this study, PF was various in regards to their adjuvant effects on the immune responses stimulated the T lymphocyte cells to secrete cytokines. As shown in Figure 3A and 3B, PF could significantly increased the production of Th1 cytokines IL-2 and IFN-γ, which suggested that PF simultaneously elicited a Th1 immune response. These findings are consistent with Blonska’s study which demonstrated that PF could improve the activity of T lymphocyte, increase the secretion of some cytokines, such as IL-2 and TNF-α, thus enhance immune function of organism [25].

Th1 immune activation contributes to cell-mediated immunity whereas Th2 immune activation favours the humoral immune response [26]. Th1/Th2 balance is a prerequisite for the functionality of immune system against infections. The immunomodulatory of PF has been widely investigated lately, both in vivo and in vitro [27]. PF has been advised to be used as a promising adjuvant material on duck inactivated vaccines [28]. Important functional properties of immune cells are their capability to synthesize and secrete soluble polypeptide factors referred to as cytokines. Most secreted cytokines are bind to specific receptors on the surface of target cells. Upon binding they act to regulate differentiation, growth and/or to optimize the immune response [29]. Using a Polish sample, Ansorge reported that propolis had immunoregulatory effects that might be regulated by Erk2 MAPK signals that improve cellular growth [30]. In T cell dependent immune response, the specific antibody produce need a progressive change in the predominant immunoglobulin class, which is adjusted by T cells and their cytokines. IL-4 and IL-10 preferentially switches activated B cells to the IgG1 isotype (Th2 type immune response), IL-2 and IFN-γ enhances IgG2 and IgG3 responses (Th1 type immune response) [31].

Conclusion

PF significantly increased the serum levels of IgM and IgG2/3, as well as T lymphocyte proliferation when administered in sows with an inactivated vaccine against PPV. The enhanced IgG subclasses levels paralleled the increased cytokine levels of IFN-γ and IL-2. This adjuvant characteristic and activity was evident in both cellular and humoral immune responses, and PF could be exploited to a new PPV vaccine adjuvant in sows.

Acknowledgements

The project was jointly supported by Shandong Province National Natural Science Foundation (Grant No.Y2005D10) and Henan Province National Natural Science Foundation of Education Department (Grant No. 13A230383, 14A230012). The authors would like to grateful to all other staff in the experiments for their assistances.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 7871
  • [From(publication date):
    March-2016 - Jul 24, 2017]
  • Breakdown by view type
  • HTML page views : 7810
  • PDF downloads :61
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords